A middle-aged man with short dark hair smiles at the camera. He is wearing a navy blue collared shirt and is set against a plain dark gray background.

Joseph F. Goldberg, MD, MS

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

  • 82Articles
  • 415.3KReads1
  • 1998–2026Active
  • 175Collaborators
  • 516Citations2
Back to top Open menu arrow
Early Career psychiatrists Authors and Reviewers Submit to JCP
JCP
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
ASCP Corner

What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination

June 9, 2025

This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
,
JCP
What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?
ASCP Corner

What Is Meant by the Term “Deprescribing,” and Does It Belong in Our Lexicon?

June 2, 2025

The authors encourage the field to destigmatize the term “deprescribing” from its misappropriated usage, explicate its accurate definition, and reclaim its purposeful meaning.
, , , et al
JCP
Valproate and Weight Gain: A New Look at an Old Problem
Commentary

Valproate and Weight Gain: A New Look at an Old Problem

March 27, 2024

Dr Goldberg comments on a recent cohort study demonstrating a dose relationship with weight gain liability for valproate.
JCP
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders?
ASCP Corner

Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders?

January 31, 2024

This article provides a practical overview of the evidence supporting lamotrigine’s efficacy and identifies shortcomings of previous study designs.
JCP
Lurasidone and Anxiety Symptoms in Bipolar Depression
Original Research

Lurasidone and Anxiety Symptoms in Bipolar Depression

June 7, 2023

Lurasidone was superior to placebo at reducing anxiety in bipolar depression. Change in anxiety symptoms was predicted by sleep disturbance at baseline.
, , , et al
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

In Memoriam: Robert M. A. Hirschfeld, MD

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
Addressing Unmet Needs in Bipolar Disorder
Academic Highlights

Addressing Unmet Needs in Bipolar Disorder

November 16, 2022

Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are...
, ,
JCP
Living in a Pharmacologically Imperfect World
Editorial

Living in a Pharmacologically Imperfect World

October 12, 2022

Joseph F. Goldberg, MD, comments on prescription of valproate in women of reproductive potential, and the risk-benefit analysis involved with choosing the least imperfect treatment option.
JCP
Recognizing Bipolar Disorder in Pregnant and Postpartum Women
Editorial

Recognizing Bipolar Disorder in Pregnant and Postpartum Women

July 13, 2022

In this editorial, Drs Freeman and Goldberg comment on a meta-analysis by Masters and colleagues on the prevalence of bipolar disorder in perinatal women.
,
JCP
Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels
Letter to the Editor

Recognizing Impaired Decisional Capacity in Vaccine Refusal: Reply to Kels and Kels

February 1, 2022

The authors reply to a letter commenting on Dr Goldberg’s JCP editorial examining COVID-19 vaccine hesitancy.
,
JCP
Commentary

Ketamine and Cognitive Function in Depression

January 4, 2022

This commentary discusses the review by Vaccarino and colleagues of cognitive effects associated with ketamine treatment for major depressive disorder.
JCP
Academic Highlights

Diagnosing and Treating Bipolar Depression

October 12, 2021

Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe